Latest News

Eczema severity, time spent on management strongly associated with overall disease burden


 

FROM JAMA DERMATOLOGY

Among 1,065 adults with atopic dermatitis (AD) who were surveyed about their condition, no single element of disease burden, including sleep, stood out as having a strong association with overall disease burden. However, AD severity and spending 11 hours or more per week managing the condition did correlate with higher overall disease burden.

“Research has documented the disease burden of AD, including its visible nature and the effect on itch and sleep, but knowledge gaps remain,” Aaron M. Drucker, MD, of the division of dermatology at the University of Toronto, and colleagues wrote in the study published online in JAMA Dermatology. “Gaps include a poor understanding of symptoms other than itch, patients’ treatment experience, and how different elements of burden of disease interact.”

eczema on the back ©aniaostudio/Thinkstock.com

Dr. Drucker and colleagues collected data from an externally led patient-focused drug development survey on AD, a 32-item questionnaire that was administered electronically between Aug. 1, 2019, and Oct. 11, 2019. Respondents were asked to rate the overall impact of their AD in the past months and the specific elements of disease burden on a 1-5 scale, with 1 meaning no impact, and 5 meaning a significant impact. They were also asked to rate current mood changes and mood changes at the worst point of AD on a 4-point scale that ranged from “not present” to “severe.” The researchers used multivariable ordinal regression to examine associations between demographic and clinical variables and patient-reported overall AD impact scores.

Survey results

Of the 1,065 respondents, 33% were aged 18-34 years, 50% were aged 35-50 years, 17% were aged 65 years or older, and 83% were female. Nearly half (45%) reported having moderate AD, while 28% had severe AD. When asked about the overall disease burden of AD symptoms in the past month, 30% reported a significant impact on life, 28% reported a moderate impact score, 21% reported a high impact score, 18% reported a low impact score, and 3% of respondents reported no impact.

In the multivariable proportional odds analysis, moderate AD (odds ratio [OR], 4.13) and severe AD (OR, 13.63) were both associated with greater disease burden compared with mild AD. Also, spending 11 or more hours per week managing AD symptoms was associated with greater disease burden compared with 0 to 4 hours (an OR of 2.67 for 11-20 hours per week spent managing AD and OR of 5.34 for 21 or more hours per week spent managing AD).

Correlations between specific impact domains such as sleep, cognitive thinking, and physical activity and overall AD impact scores ranged from weak to moderate, and no individual aspect of disease burden correlated strongly with overall impact scores. The researchers observed similar results after they stratified the analysis by age, current severity, and time spent managing AD.

In other findings, 40% of study participants reported mild changes in mood related to their AD, 30% reported moderate changes, 9% reported severe changes, while the remainder reported no changes in mood. The variable most strongly associated with current mood changes was having severe AD at the time of the survey (OR 5.29).

Pages

Recommended Reading

Dupilumab effective in adults with moderate-to-severe atopic dermatitis in real world
MDedge Dermatology
Meta-analysis shows protective effect of probiotics on infantile atopic dermatitis
MDedge Dermatology
Probiotic supplementation beneficial in adults with atopic dermatitis
MDedge Dermatology
Atopic dermatitis: Face masks may be protective on facial eczema and may enhance dupilumab efficacy
MDedge Dermatology
Atopic dermatitis: Real-world analysis of characteristics of patients initiating dupilumab
MDedge Dermatology
Contact hypersensitivity to preservatives in adults with atopic dermatitis
MDedge Dermatology
Low prevalence of keratosis pilaris in atopic dermatitis
MDedge Dermatology
Introduce allergens early, say French allergists
MDedge Dermatology
Antibiotics during pregnancy may increase child’s risk for asthma and other atopic diseases
MDedge Dermatology
Commentary: Support for the Use of Dupilumab in AD, and a Link Between AD and Depression, July 2022
MDedge Dermatology